AML with mutated NPM1

Clinical trials for AML with mutated NPM1 explained in plain language.

Never miss a new study

Get alerted when new AML with mutated NPM1 trials appear

Sign up with your email to follow new studies for AML with mutated NPM1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New cell therapy aims to stop blood cancer relapse in tough-to-treat patients

Disease control Cancelled

This early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goals are to check safety and see if it can prevent the cancer from coming …

Matched conditions: AML WITH MUTATED NPM1

Phase 1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

AML with mutated NPM1

Get alerted when new AML with mutated NPM1 trials appear

New cell therapy aims to stop blood cancer relapse in tough-to-treat patients